Enzo Biochem Inc (ENZ)
1.04
0.00 (0.00%)
USD |
NYSE |
May 03, 16:00
1.045
0.00 (0.00%)
Pre-Market: 20:00
Enzo Biochem Cash from Financing (Quarterly): -0.022M for Jan. 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | -0.022M |
| October 31, 2023 | -0.518M |
| July 31, 2023 | -4.24M |
| April 30, 2023 | 3.272M |
| January 31, 2023 | -0.062M |
| October 31, 2022 | -0.095M |
| July 31, 2022 | -0.096M |
| April 30, 2022 | -0.031M |
| January 31, 2022 | -0.057M |
| October 31, 2021 | -0.057M |
| July 31, 2021 | -0.056M |
| April 30, 2021 | 0.021M |
| January 31, 2021 | -0.094M |
| October 31, 2020 | -0.113M |
| July 31, 2020 | -0.09M |
| April 30, 2020 | 7.32M |
| January 31, 2020 | -0.058M |
| October 31, 2019 | -0.171M |
| July 31, 2019 | -0.157M |
| April 30, 2019 | -0.106M |
| January 31, 2019 | 4.49M |
| October 31, 2018 | -0.034M |
| July 31, 2018 | 0.027M |
| April 30, 2018 | 0.012M |
| January 31, 2018 | -0.037M |
| Date | Value |
|---|---|
| October 31, 2017 | 0.557M |
| July 31, 2017 | 0.156M |
| April 30, 2017 | -0.016M |
| January 31, 2017 | -2.112M |
| October 31, 2016 | 0.303M |
| July 31, 2016 | -0.56M |
| April 30, 2016 | -1.179M |
| January 31, 2016 | -0.067M |
| October 31, 2015 | -0.125M |
| July 31, 2015 | -0.146M |
| April 30, 2015 | 1.26M |
| January 31, 2015 | 2.904M |
| October 31, 2014 | 2.207M |
| July 31, 2014 | 1.993M |
| April 30, 2014 | 5.212M |
| January 31, 2014 | 1.743M |
| October 31, 2013 | 1.969M |
| July 31, 2013 | 4.999M |
| April 30, 2013 | -0.101M |
| January 31, 2013 | -0.055M |
| October 31, 2012 | -0.028M |
| July 31, 2012 | -0.049M |
| April 30, 2012 | -0.037M |
| January 31, 2012 | -0.035M |
| October 31, 2011 | -0.033M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-4.24M
Minimum
Jul 2023
7.32M
Maximum
Apr 2020
0.2472M
Average
-0.062M
Median
Jan 2023
Cash from Financing (Quarterly) Benchmarks
| Delcath Systems Inc | 0.001M |
| Star Equity Holdings Inc | 0.987M |
| Exact Sciences Corp | 10.04M |
| CytoSorbents Corp | 12.21M |
| Progyny Inc | -5.025M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -8.938M |
| Cash from Investing (Quarterly) | -0.025M |
| Free Cash Flow | -45.92M |
| Free Cash Flow Per Share (Quarterly) | -0.1775 |
| Free Cash Flow to Equity (Quarterly) | -9.361M |
| Free Cash Flow to Firm (Quarterly) | -8.963M |
| Free Cash Flow Yield | -88.36% |